{"entity": "researcher", "timestamp": "2026-09-23T21:35:51.839Z", "family": "Jensen", "given": "Helene K", "initials": "HK", "orcid": "0000-0003-4669-133X", "affiliations": ["Clinical Pharmacology and Pharmacy, Department of Public Health, University of Southern Denmark, Denmark."], "links": {"self": {"href": "https://publications-affiliated.scilifelab.se/researcher/0f2bb5f699f4478db9ee30639f31febb.json"}, "display": {"href": "https://publications-affiliated.scilifelab.se/researcher/0f2bb5f699f4478db9ee30639f31febb"}}, "publications": [{"entity": "publication", "iuid": "ba9985751de04ea8bade892117cf7f6e", "links": {"self": {"href": "https://publications-affiliated.scilifelab.se/publication/ba9985751de04ea8bade892117cf7f6e.json"}, "display": {"href": "https://publications-affiliated.scilifelab.se/publication/ba9985751de04ea8bade892117cf7f6e"}}, "title": "Use of non-insulin antidiabetic drugs in children and young adults - A Scandinavian drug utilization study from 2010-2019.", "authors": [{"family": "Jensen", "given": "Helene K", "initials": "HK", "orcid": "0000-0003-4669-133X", "researcher": {"href": "https://publications-affiliated.scilifelab.se/researcher/0f2bb5f699f4478db9ee30639f31febb.json"}}, {"family": "Rasmussen", "given": "Lotte", "initials": "L", "orcid": "0000-0001-5962-6647", "researcher": {"href": "https://publications-affiliated.scilifelab.se/researcher/b6a270c0d778409dace2e3ff4d7f181b.json"}}, {"family": "Furu", "given": "Kari", "initials": "K"}, {"family": "Karlstad", "given": "\u00d8ystein", "initials": "\u00d8", "orcid": "0000-0003-1204-787X", "researcher": {"href": "https://publications-affiliated.scilifelab.se/researcher/444d55a5814c4342a44da5f6488b6e23.json"}}, {"family": "Linder", "given": "Marie", "initials": "M"}, {"family": "Cesta", "given": "Carolyn E", "initials": "CE"}, {"family": "Potteg\u00e5rd", "given": "Anton", "initials": "A", "orcid": "0000-0001-9314-5679", "researcher": {"href": "https://publications-affiliated.scilifelab.se/researcher/1daf4d9300f94bf6916f968437b52a80.json"}}], "type": "journal article", "published": "2021-11-00", "journal": {"title": "Br J Clin Pharmacol", "issn": "1365-2125", "volume": "87", "issue": "11", "pages": "4470-4475", "issn-l": null}, "abstract": "Knowledge on utilization patterns of non-insulin antidiabetic drugs in childhood and youth is limited. Therefore, we conducted a population-based drug utilization study using publicly available aggregate data on use of non-insulin antidiabetics from 2010 to 2019 in Scandinavia (Denmark, Norway and Sweden) in individuals aged up to 24 years. For each non-insulin antidiabetic drug, we calculated the annual prevalence proportion of users, overall and for specific age groups. From 2010 to 2019, the prevalence of non-insulin antidiabetic users in Scandinavia increased 37% from 0.43 to 0.59/1000 individuals. The prevalence proportions were highest among female adolescents and young adults, but the largest relative increase in use was seen among 10-14-year-olds (78%). Metformin was by far the most widely used non-insulin antidiabetic drug with a prevalence proportion of 0.51/1000 in 2019, followed by glucagon-like peptide-1 (GLP-1) analogues, which, however, showed an eight-fold relative increase during the study period.", "doi": "10.1111/bcp.14867", "pmid": "33871080", "labels": [], "xrefs": [], "notes": [], "created": "2026-09-23T13:11:05.971Z", "modified": "2026-09-23T13:11:06.119Z"}]}